SCHEMBL1013330

SCHEMBL1013330

O=C(O)CC(=O)Nc1cccc(-c2ccoc2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.60
SERPINE1 P05121 3/20 0.54
MGLL Q99685 1/20 0.47
HDAC1 Q13547 5/20 0.47
HDAC6 Q9UBN7 5/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HDAC2 Q92769 5/20 0.46
HDAC3 O15379 4/20 0.46
HDAC4 P56524 4/20 0.46
HDAC7 Q8WUI4 4/20 0.46
HDAC10 Q969S8 4/20 0.46
HDAC11 Q96DB2 4/20 0.46
HDAC8 Q9BY41 4/20 0.46
HDAC9 Q9UKV0 4/20 0.46
HDAC5 Q9UQL6 4/20 0.46
CFD P00746 1/20 0.46
KCNK3 O14649 1/20 0.46
KCNK9 Q9NPC2 1/20 0.46
PPARD Q03181 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13476524 0.83 MGLL (0.68) CNR1MGLLHDAC1HDAC6MEN1
SCHEMBL1016744 0.82 CNR1 (0.63) CNR1SERPINE1MGLLHDAC2KCNK3
SCHEMBL1013662 0.82 CNR1 (0.53) CNR1SERPINE1MEN1KMT2ACYP3A4
SCHEMBL1012706 0.79 SERPINE1 (0.80) CNR1SERPINE1MEN1KMT2A
SCHEMBL27964990 0.77 CNR1 (0.64) CNR1SERPINE1MGLLMEN1KMT2A
SCHEMBL29492570 0.76 SERPINE1 (0.59) CNR1SERPINE1HDAC1HDAC6MEN1
SCHEMBL30469260 0.75 CNR1 (1.00) CNR1SERPINE1
SCHEMBL20557721 0.75 CNR1 (1.00) CNR1SERPINE1
SCHEMBL1015834 0.75 CNR1 (0.54) CNR1SERPINE1KMT2A
SCHEMBL1014817 0.74 SERPINE1 (0.76) CNR1SERPINE1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 CNR1 3950/4885SERPINE1 1/4885MGLL 1930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.